Management of Recently Diagnosed Rheumatic Heart Disease
All patients with newly diagnosed rheumatic heart disease must immediately begin long-term antibiotic prophylaxis to prevent recurrent rheumatic fever, which will worsen their valvular disease and increase mortality risk. 1, 2
Immediate Antibiotic Prophylaxis (Secondary Prevention)
This is the cornerstone of management and takes absolute priority. The preferred regimen is:
First-line: Penicillin G benzathine 1.2 million units intramuscularly every 4 weeks 1, 2
- In high-risk situations, administration every 3 weeks may be needed 2
Alternative regimens (if penicillin unavailable or contraindicated):
- Penicillin V potassium 250 mg orally twice daily 2
- Sulfadiazine 1 g orally once daily 2
- Macrolide or azalide antibiotic (for penicillin/sulfadiazine allergy) 2
- Critical caveat: Do not use macrolides if patient takes medications inhibiting cytochrome P450 3A (azole antifungals, HIV protease inhibitors, certain SSRIs) 2
Duration of Prophylaxis
The duration depends on whether residual heart disease is present:
With documented valvular heart disease (your patient): Minimum 10 years OR until age 40 (whichever is longer) 1, 2
Consider lifelong prophylaxis if:
Critical point: Secondary prophylaxis must continue even after valve replacement surgery 1, 2
Cardiovascular Risk Factor Management
Standard guideline-directed medical therapy for cardiac risk factors must not be neglected 1, 2:
- Hypertension management (but avoid abrupt blood pressure lowering in stenotic lesions) 1, 2
- Diabetes control
- Hyperlipidemia treatment
- Heart-healthy lifestyle: regular aerobic exercise, healthy diet, smoking cessation, normal body weight 1
Exercise Recommendations
- Regular aerobic exercise improves cardiovascular fitness and symptoms in asymptomatic patients 1, 2
- Avoid heavy isometric repetitive training (increases LV afterload) 1
- Light resistive training with small free weights is acceptable 1
Heart Failure Management (If Applicable)
If your patient has LV systolic dysfunction and severe valvular disease but intervention is not feasible or declined, use standard heart failure therapy 1, 2:
- Diuretics for volume overload
- ACE inhibitors or ARBs
- Beta blockers
- Aldosterone antagonists
- Sacubitril/valsartan
- Biventricular pacing (if indicated)
Important: Most patients with severe valvular disease and LV dysfunction will ultimately need valve intervention 1
Infective Endocarditis Prophylaxis
Antibiotic prophylaxis before dental procedures is reasonable (Class IIa recommendation) for patients with rheumatic heart disease undergoing procedures involving 2:
- Manipulation of gingival tissue
- Manipulation of periapical region of teeth
- Perforation of oral mucosa
However: Patients already receiving benzathine penicillin G for rheumatic fever prophylaxis may not need additional endocarditis prophylaxis for dental procedures 3
Not recommended: Prophylaxis for non-dental procedures (TEE, colonoscopy, cystoscopy) in absence of active infection 2
Most important: Optimal oral health maintenance is the most effective intervention to prevent valve infection 2, 4
Vaccinations
Follow standard recommendations for:
Monitoring and Follow-up
Establish regular cardiology follow-up to:
- Monitor valvular disease progression
- Ensure adherence to antibiotic prophylaxis (this is critical—recurrent rheumatic fever worsens valve disease) 1, 2
- Assess for symptoms requiring intervention
- Perform serial echocardiography based on disease severity 5
Critical Pitfalls to Avoid
- Never delay starting antibiotic prophylaxis—recurrent rheumatic fever can occur even with asymptomatic streptococcal infections 1, 2
- Do not discontinue prophylaxis after valve surgery—it must continue 1, 2
- Avoid abrupt blood pressure lowering in patients with stenotic lesions 1, 2
- Ensure proper injection technique for benzathine penicillin G—injections are painful and require competent administration 6
- Remember that group A streptococcus infection doesn't need to be symptomatic to trigger recurrence 1, 2
The evidence strongly supports that preventing recurrent rheumatic fever through long-term antimicrobial prophylaxis is more effective than attempting to recognize and treat acute streptococcal episodes 1, 2. This approach directly reduces morbidity and mortality by preventing progressive valvular damage.